Chembio diagnostics reports inducement award under nasdaq listing rule 5635(c)(4)

Hauppauge, n.y., jan. 06, 2022 (globe newswire) -- chembio diagnostics, inc. (nasdaq: cemi), a leading point-of-care diagnostic company focused on infectious diseases, today reported that, in accordance with nasdaq listing rule 5635(c)(4), it has granted a nonqualified stock option and a restricted stock unit award to lawrence j. steenvoorden, chembio's new chief financial officer and executive vice president, outside of any stock equity plan. the awards were granted upon mr. steenvoorden's joining chembio on january 5, 2022, in accordance with terms of his employment agreement with chembio, which was entered into on december 30, 2021 and became effective as of january 5, 2022.
CEMI Ratings Summary
CEMI Quant Ranking